OliX Pharmaceuticals raises KRW 110 billion from BOLD and Weiss for advancing siRNA-based projects.
Amount Raised
₩110 Billion
Round Type
Post-IPO Equity
South KoreaBiotechnologyProfessional ServicesHealth CareScience And EngineeringInvestors
Description
OliX Pharmaceuticals has raised approximately KRW 110 billion through a third-party allotment of newly issued common shares to strategic investors. The investment was made by BOLD, L’Oréal’s corporate venture capital fund, and Weiss Asset Management LP. With the funds, OliX intends to advance its siRNA-based projects targeting skin and hair therapies. The investment will also strengthen its strategic partnership with L’Oréal.
Quick answer
OliX Pharmaceuticals raised ₩110 Billion in a Post-IPO Equity round, dated June 4, 2026. Investors: Weiss Asset Management LP, L’oréal Corporate Venture Capital Fund and Bold. OliX Pharmaceuticals is based in South Korea.
- How much did OliX Pharmaceuticals raise?
- OliX Pharmaceuticals raised ₩110 Billion in a Post-IPO Equity round on June 4, 2026.
- Who invested in OliX Pharmaceuticals?
- Weiss Asset Management LP, L’oréal Corporate Venture Capital Fund and Bold are named as investors in this round.
- What does OliX Pharmaceuticals do?
- OliX Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics against a variety of disorders by down-regulating the expression of disease-causing genes based on its own proprietary RNAi..
- Where is OliX Pharmaceuticals based and how big is it?
- OliX Pharmaceuticals is based in South Korea.
- Who are the decision-makers at OliX Pharmaceuticals?
- Fundz holds 1 contact at OliX Pharmaceuticals, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Professional Services and Science And Engineering around the same time
Companies in the same sectors as OliX Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised $6M (Post-IPO Equity) on June 18, 2026.
- Advanced NanoTherapies raised $31M (Series B) on June 2, 2026.
- Psilera raised $8.8M (Seed) on May 28, 2026.
- Degron Therapeutics raised $40M (Series A) on May 14, 2026.
- Maze Therapeutics raised $145M (Post-IPO Equity) on April 22, 2026.
- Ray Therapeutics raised $125M (Series B) on April 21, 2026.
Who to call at OliX Pharmaceuticals, and when
A new round usually means OliX Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OliX Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OliX Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OliX Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OliX Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OliX Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.